KVM Hemoglobin Lysing Reagent

FDA 510(k) K883991 · Kvm Technologies, Inc.

Substantially Equivalent

510(k) numberK883991

Submission

Device name
KVM Hemoglobin Lysing Reagent
Applicant
Kvm Technologies, Inc.
Houston, TX, US
Received
September 20, 1988
Decision date
October 12, 1988
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)

Official FDA 510(k) record

Device classification

Product code
GGK – Products, Red-Cell Lysing Products
Device class
Class I (low risk)
Regulation
21 CFR 864.8540
Specialty
Hematology

Other 510(k)s with product code GGK

510(k)DeviceApplicantDecision
K883836Coulter Clone Quick Stain Whole Blood Lyse-IiGGK · Traditional Coulter Immunology11/30/1988SE
K874054Fisher Diagnostics Hematall III Las ReagentGGK · Traditional Fisher Scientific Co., LLC10/20/1987SE
K873348Cell-Dyn Diff Screen, Auto. & Semi Auto. Lytic Ag.GGK · Traditional Abbott Diagnostics09/09/1987SE
K863114PiastrinitGGK · Traditional J. D. Assoc.11/06/1986SE
K863503HemolyseGGK · Traditional Reagent Laboratory, Inc.10/03/1986SE
K850944Nsi Lysing-D Reagent -4000 MLGGK · Traditional Nobel Scientific Industries, Inc.03/29/1985SE
K850097Laser-LyseGGK · Traditional Hematology Marketing Assoc.03/29/1985SE
K842938Acetic Acid 1% V/VGGK · Traditional E K Ind., Inc.09/14/1984SE
K842937Acetic Acid 2% V/VGGK · Traditional E K Ind., Inc.09/12/1984SE
K842936Acetic Acid, 3% V/VGGK · Traditional E K Ind., Inc.09/12/1984SE

More from E K Ind., Inc.

510(k)DeviceDecision
K925666Therapacer 3000BXB · Traditional 03/09/1993SE
K883992KVM Prepack Hematology Reagent SetGKK · Traditional 10/12/1988SE
K883990KVM Isotonic DiluentGIF · Traditional 10/12/1988SE
K883989KVM Isotonic Flush SolutionGIF · Traditional 10/12/1988SE

Questions and answers

When was KVM Hemoglobin Lysing Reagent cleared by the FDA?

KVM Hemoglobin Lysing Reagent (K883991) received a 510(k) decision of Substantially Equivalent on October 12, 1988, 22 days after the submission was received.

What is the product code of K883991?

The FDA product code is GGK – Products, Red-Cell Lysing Products, a Class I (low risk) device regulated under 21 CFR 864.8540.